Wishing You And Your Family Health,
Happiness, Peace & Prosperity
This Holiday Season.
Friday, December 25, 2020
Thursday, December 24, 2020
Please Rollover Nickel Short Positions In January 2021 Series...
Given To All Of You As A Free Live Trades On 14th October 2020
MCX Nickel December
2 Lots Short Sell Given 1136
Now Cmp: 1290
Please Rollover Now In January 2021 Series
Now Cmp: 1266
Now Our Costing For 2 Lots Nickel Is Now 1112
HOLD WITHOUT STOPLOSS FOR HUGE RETURN ONLY
SO FOR TIME BEING POSITION OPEN WITHOUT STOPLOSS
Pay Now & Join Super Signature HNI Positional Profit Plan, Call
09980555517
Friday, December 18, 2020
Please Book MCX CrudeOil At 3603 & Also Rollover The Positions In January 2021
MCX CrudeOil December
BOOK INFY NOW AT 1194
Given To You As A Free Live Trade On The Date Of 23rd Oct 2020, Check here:
https://twitter.com/arbindtiwariT/status/1319519053216559105
Also Given Here On My Blog Also
Friday, December 11, 2020
BHEL Next Move
The country's largest power generation equipment manufacturer Bharat Heavy Electricals Ltd. has been in focus on their plans to pushing government’s ‘Make in India’ initiative. The company has plans to seek global partners who wish to manufacture in India and could emerge as an engineering R&D services provider, a contract manufacturer, or a lessor of urban-area industrial land.
BHEL said they will diversify beyond power and thermal sectors. “We will grow from a power Sector Company to a global engineering organization. The company can look to diversify into sectors like Railways, Defence, Aerospace and Oil & Gas.
BHEL has won a prestigious order for the supply of state-of-the-art Electric Buses along with charging infrastructure of these buses for Gorakhpur City. The order has been placed on BHEL by the Urban Transport Directorate (UTD), Lucknow. These low floor, disabled-friendly Electric Buses will be deployed by UTD at the Gorakhpur airport. This is in line with the company’s transformation initiative of expanding into new markets/businesses. Further, as part of the transformation journey, BHEL is consolidating and reinvigorating the initiatives taken in Defence & Aerospace, Water, E-mobility, Batteries, Renewables and Transportation businesses.
Amidst stiff competitive bidding, BHEL has won its first commercial order for state-of-the-art Battery Energy Storage Systems from The Energy and Resource Institute (TERI). The company has signed a contract agreement with TERI for setting up of a cumulative 410 kWh Battery Energy Storage Systems (BESS) in the National Capital Territory (NCT) of Delhi. The tender was issued by TERI on turnkey basis under UI-ASSIST (US-India Collaborative for Smart Distribution System with Storage) initiative with BSES Rajdhani Power Limited (BRPL).
BHEL’s scope of work in the contract includes design, supply, testing, installation & commissioning along with a comprehensive five-year AMC of the systems at three different locations. The project will be executed by BHEL’s Electronics Division, Bengaluru. BHEL has a focused approach in the emerging field of BESS and has already commissioned a 1 MWh BESS at its Corporate R&D Centre located in Hyderabad. The state-of-the-art system is commissioned with three different battery technologies viz. Lithium-Ion, Advance Lead-Carbon and Flow batteries.
BHEL has embarked upon a transformation journey and is actively pursuing diversification of its portfolio in non-coal segments viz. Energy Storage, E-Mobility, Oil & Gas, Transportation, Defence and Aerospace, etc. With its vast experience of more than five decades of indigenized manufacturing, BHEL is geared to provide tailor-made solutions for Battery Energy Storage Systems to meet different kinds of customer requirements.
BHEL, the country’s largest and oldest capital goods manufacturing company has successfully manufactured and tested (short circuit) India’s highest rating Auto Transformer at the National High Power Test Laboratory (NHPTL) at Bina in Madhya Pradesh. Significantly, this is a new benchmark in the global transformer industry. Short circuit test is the most stringent, special type test for power transformers which is conducted to prove the adequacy for power transformers to withstand abnormal conditions of a short circuit to ensure reliability during their operations in the field.
Incidentally, this is BHEL’s 21st 400 kV class transformer, which has successfully passed the short circuit test, indicating the company’s prowess in the sector. This 500 MVA 400/220/33 kV Autotransformer has been designed and manufactured at BHEL’s Bhopal plant for UP Power Transmission Corporation Limited. These high rating transformers play a crucial role in bulk power transmission to load centres and bigger cities.
BHEL is the largest manufacturer of power transformers in India and a pioneer in the indigenous development of higher rating and specialized transformers, with voltage levels going up to 1200 kV class. BHEL’s Transformer Plant at Bhopal has a world-class, state-of-the-art facility, which is at par with its global peers and is fully equipped to meet the expectations of utilities in India as well as abroad in the entire range of Power Transformers and Shunt Reactors.
In line with its objective of achieving excellence in project execution, Bharat Heavy Electricals Limited has implemented an innovative boiler cleaning process for coal-fired thermal units, at NTPC’s 3x660 MW North Karanpura Super Thermal Power Project, being executed by BHEL on EPC basis. The boiler commissioning cycle will reduce from 100 days to 80 days by successfully completing the main ‘Boiler Acid cleaning’ without its light-up, by using an Auxiliary Boiler. This innovative method is a major change in the commissioning process followed so far and will aid in early synchronization of the unit.
BHEL has a proven track record in the supercritical segment and has successfully commissioned 23 boiler packages and 19 turbine packages in the ratings of 660 MW, 700 MW and 800 MW. BHEL has so far contracted 58 boilers and 53 turbine packages of supercritical sets including many on EPC mode, which is the most by any single domestic power plant equipment manufacturer.
BHEL is trading at a price of INR 35.85 on 12.11.2020.
Long-term investors can reap rewards.
BUY RECOMMENDATION FROM ARBIND TIWARI FOR TARGET 75/90
Friday, December 4, 2020
Tuesday, November 24, 2020
Open Positions On Blog
#INFY Future December
#MCX CrudeOil December
#MCX Nickel December
Hold Only For Huge Return..
Pay Now & Join Super Signature HNI Positional Profit Plan, Call
09980555517
Ask Bank Details For Subscriptions If You Have Rs. 50 Lac+++
09900017008
Saturday, November 21, 2020
Minimum Return / Stocks More Then 25%
After Filter Got #Six Stocks Futures 4 U
Now I Can Expect Big Moves In That 6 Stocks Minimum Return / Stocks More Then 25% 5 Lots Each 30 Lots Total Holding.. Minimum Required Capital: Rs. 70 Lac Total Quantity: 55255 Risk Rs. 20 Lac Return Rs. 1.50 Crore Accuracy 100%Friday, November 20, 2020
My Personal View For TATASTEEL
TATASTEEL
LTP: 533
Expected Upside: 675
Its My Personal View For This Target 675. Buy Recommendations For All The Investors or Traders. Medium Term To Long Term Prospective. All the Fundamentals & Technical Levels Also Providing Indications For Strong Buy.
For More Details, Call Me
+91 9980555517
Whats App Me
+91 9900017008
My View On ExideInd
Exide Industries
LTP: 171.50
Expected Upside: 205
"Exide Industries reported better than expected results as sales/EBITDA/net profit were higher than our forecasts by 11/19/27 percent. We raise FY21 sales/EBITDA/EPS estimates by 6/11/14 percent respectively given better than expected Q2FY21 results. We also raise FY22 estimates by 4/7/9 percent. Our SOTP based target price (based on FY23 earnings) stands at Rs 205". Its My personal view and 100% buy recommendations for all traders or investors. I believe to hold positions from short term to long term. This target is for very short term to mid term period.
For More Details, Call Me
+91 9980555517
Whats App Me
+91 9900017008
My View On A Pharmaceutical Stock That Not Moved Still But Very Soon ๐๐๐๐๐๐๐๐๐๐๐งจ๐๐๐
Sun Pharmaceutical Industries
LTP: Rs 503.80
Target price: Rs 618
Expected Upside More Then Written Price
The brokerage believes the US business for Sun Pharma (excluding Taro Pharmaceuticals and Dusa Pharmaceuticals) should start growing as 92 ANDAs (abbreviated new drug applications) and 6 NDAs, which are pending approval, gradually start reflecting in incremental revenues.
Price erosion in base business is unlikely to be painful as the same is now commoditised with a median competitive intensity of eight players across its marketed ANDA portfolio.
In addition to complex ANDAs, Sun Pharma is also aggressively developing value-added generic drugs that are targeting the following segments:
1) Patients suffering from dysphagia.
2) Dosing convenience.
3) Improved health care administration.
The domestic business should deliver a low double-digit growth and outpace the Indian pharmaceutical market driven by its large exposure to the chronic segment. the brokerage said.
For More Details, Call Me
+91 9980555517
Whats App Me
+91 9900017008
#เคเค เคชूเคा
Greetings and best wishes on the occasion of #chhathPuja,
a festival dedicated to worshiping of Sun God.
May all be blessed with good health, happiness, and prosperity.#เคเค เคชूเคा
@arbindtiwariT
Subscribe to:
Posts (Atom)